If Artemisinin Drugs Fail, What's Plan B?Martin Enserink
If the current generation of artemisinin-based combination therapies (ACTs) should fail, does the world have a solid backup plan? The short answer: No. New funding has lured academics and pharmaceutical companies back to the malaria field after a decades-long drought. But drug development is a slow process, and the only compounds far enough along in the pipeline to quickly replace current ACTs are variations on the artemisinin theme. Whether they will kill resistant parasites is a big question
http://www.sciencemag.org/cgi/content/summary/328/5980/846
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment